Cargando…
Can sacubitril/valsartan become the promising drug to delay the progression of chronic kidney disease?
Autores principales: | CHEN, Yang, GUO, Lu-Ying, ZHAO, Ling-Fei, MA, Yan-Hong, ZHU, Xue-Ling, XU, Ying, CHEN, Jiang-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Science Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762693/ https://www.ncbi.nlm.nih.gov/pubmed/33424946 http://dx.doi.org/10.11909/j.issn.1671-5411.2020.12.002 |
Ejemplares similares
-
Sacubitril/Valsartan Conundrum
por: Somberg, John
Publicado: (2021) -
Effect of sacubitril/valsartan or valsartan on ventricular remodeling and myocardial fibrosis in perimenopausal women with hypertension
por: Chen, Jianshu, et al.
Publicado: (2023) -
Effects of sacubitril-valsartan in patients undergoing maintenance dialysis
por: Ding, Ying, et al.
Publicado: (2023) -
Emerging trends in sacubitril/valsartan research: A bibliometric analysis of the years 1995–2021
por: Lai, Ping, et al.
Publicado: (2022) -
Implication of low dose sacubitril/valsartan
por: Imamura, Teruhiko
Publicado: (2021)